Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Podcasts


Recent Episodes

Experts highlight the origins and significance of World Radiotherapy Awareness Day and discuss global access challenges surrounding modern radiation oncology.
September 2, 2026
Speaking With “One Voice” for World Radiotherapy Awareness Day
How Mentorship and Peer Support Help Oncologists Avoid Burnout
August 31, 2026
How Mentorship and Peer Support Help Oncologists Avoid Burnout
Experts discussed the rapidly expanding radiopharmaceutical paradigm and how to integrate such technology into real-world oncology practice.
August 26, 2026
Exploring the Future of Radiopharmaceutical Therapy in Oncology
Frank McCormick, PhD, FRS, DSc (Hon), spoke about how targeting KRAS may eventually lead to the prevention of pancreatic cancer.
August 24, 2026
How Will Successfully Targeting KRAS Change Pancreatic Cancer Treatment?
Experts highlight how AI-based tools can assist with digital pathology, documentation, medical imaging, and other relevant areas in genitourinary oncology.
August 21, 2026
What Role Will Artificial Intelligence Play in Genitourinary Oncology?
How to Treat Depression in Patients With Cancer: A Practical Framework
August 17, 2026
How to Treat Depression in Patients With Cancer: A Practical Framework
Two pharmacy specialists discuss real-world data and clinical trial findings on the use of CAR T-cell therapy for pediatric patients with hematologic cancers.
August 10, 2026
Exploring CAR-T Updates in Pediatric Acute Lymphoblastic Leukemia
Two hematologic oncology experts discuss operational and referral workflows, as well as barriers to access for CAR T-cell therapy in multiple myeloma.
July 31, 2026
What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?
Presenters at the 2026 National ICE-T Conference in Orlando discuss the efficacy and safety of novel agents across hematologic disease states.
July 27, 2026
Unraveling Immune Effector Therapy Advances Across Hematologic Oncology
The approval of Orca-T represents a “big advance” that must be studied further, according to Wendy Stock, MD.
July 20, 2026
How Will Orca-T Impact the Hematologic Oncology Paradigm?

All series

Recent Episodes

Recent Episodes

Oncology On the Go With ASTCT Talks

Oncology On the Go With ASTCT Talks

ONCOLOGY Decoded

ONCOLOGY Decoded

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

RadOnc on the Run with Brandon Mancini, MD, MBA, FACRO

FDA Approval Alert: The Need-to-Know

FDA Approval Alert: The Need-to-Know

Joshua Richter, MD, and Marco Davila, MD, PhD, discussed practical strategies for administering CAR T-cell therapy to patients with multiple myeloma. Their conversation touched upon key themes including navigating operational and referral workflows, dismantling access barriers to novel cellular therapies, and determining the proper candidates for treatment.

Exploring Practical CAR T Cell Use in Multiple Myeloma Care

Oncology-on-the-Go with Daniel C. McFarland, DO

Oncology-on-the-Go with Daniel C. McFarland, DO

Advertisement
Advertisement

Trending on CancerNetwork

1

FDA Approves Camizestrant for ESR1-Mutated HR+/HER2– Advanced Breast Cancer

2

How Is AI Advancing Tumor Boards, Care Coordination, and Treatment Planning?

3

How Might WCLC 2026 Clarify the Evolving Role of APPs in Lung Cancer?

4

Saturated Fat Intake Linked to Greater Mortality in Nonmetastatic Prostate Cancer

5

Can Ropeginterferon Elicit Disease Modification in Essential Thrombocythemia?

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us